ijddr

International Journal of Drug Development and Research

ISSN - 0975-9344

- (2011) Volume 3, Issue 2

View PDF Download PDF

Effects of bittergourd (Momordica Charantia) fruit juice on glucose tolerance and lipid profile in type-l l diabetic rats

 

Author info »

Abstract

Bitter melon (Momordica charantia) or bittergourd commonly known as karella, (family: Cucurbitaceae), has been proved for hypoglycaemic effects. The objective of the present study was to evaluate effects of bittergourd (momordica charantia) fruit juice on glucose tolerance and lipid profile in streptozotocininduced type-II diabetic rat. Two days old neonatal pups (7–10 g) were used & they were made diabetic by intraperitoneally (i.p.) injection of 90 mg/kg STZ in citrate buffer solution. Different groups of animals were treated by 25% and 50% bitter gourd fruit juice (BFJ) for 8 weeks. After 8 weeks treatment biochemical parameters from blood serum were analyzed. The significant differences of glucose, cholesterol, HDL, LDL, triglyceride, in 50%BFJ treated group compare to diabetic group were found. So, from present study it is concluded that Bitter gourd fruit juice has beneficial effects on glucose tolerance and lipid profile in streptozotocin-induced type-II diabetic rat.

References

  1. International Diabetes Federation. IDF diabetes atlas. 4th ed. Brussels, Belgium: International Diabetes Federation; 2009. Available from: www.diabetesatlas.org. Accessed 2010 May 31.
  2. Wilson PW. Diabetes mellitus, and coronary heart disease. EndocrinolMetabClinNorthAm 2001;30: 857–881.
  3. Stamler J, Vaccaro O, Neaton JD, and Wentworth D. Diabetes, other risk factors, and 12iyr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16: 434–444.
  4. Sowers JR, Epstein M, and Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37: 1053–1059.
  5. Lteif AA, Mather KJ, and Clark CM. Diabetes and heart disease an evidenceidriven guide to risk factors management in diabetes. Cardiol Rev 2003; 11: 262–274.
  6. Bakris G, Sowers J, Epstein M, Williams M. Hypertension in patients with diabetes. Why is aggressive treatment essential? Postgrad Med. 2000;107:53– 6, 61–4.
  7. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension .1992;19:403–18.
  8. Weir MR. Diabetes and hypertension: blood pressure control and consequences. Am J Hypertens. 1999;12(12 Pt 1–2): 170S–8S.
  9. Yeh, G.Y., Eisenberg, D.M., Kaptchuk, T.J., Phillips, R.S. Systemic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care, 2003; 26 (4), 1277–1294.
  10. Platel K, Srinivasan K: Plant foods in the management of Diabetes mellitus: Vegetables as potential hypoglycaemic agents. Nahrung , 1997; 41:68–74
  11. Ahmed I: Effects of Momordicacharantia fruit juice on experimental diabetes and its complications. , University of Central Lancashire, 1999
  12. Welihinda J, Karunanayake EH, Sheriff MHR, Jayasinghe KSA: Effect of Momordicacharantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 1986;17: 277–282,
  13. Ahmed, I., Lakhani, M. S., Gillett, M., John, A., &Raza, H. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordicacharantia (karela) fruit extract in streptozotocin-induced rats. Diabetes Research and Clinical Practice, 2001; 51, 155–161.
  14. Akhtar, M. S., Athar, M. A., &Yaqub, M. Effect of Momordicacharantia on the blood glucose level of normal and alloxan diabetic rabbits. PlantaMedica, 1981; 42, 205–212
  15. Cakici, I., Hurmoglu, C., Tunctan, B., Abacioglu, N., Kanzik, I., &Sener, B. Hypoglycemic effect of Momordicacharantia extracts in normoglycemic or cyprohepta-diene induced hyperglycaemic mice. Journal of Ethnopharmacology, 1994; 44, 117–121.
  16. Rao, B. K., Kesavulu, M. M., &Apparao, C. Antihyperglycemic activity of Momordicacymbalaria in alloxan diabetic mice. Journal of Ethnopharmacology, 2001; 78, 67–71
  17. Lotlikar, M. M., &Rajarama, R. M. R. Pharmacology of a hypoglycemic principle: Isolated from the fruits of Momordicacharantia Linn. Indian Journal of Pharmacy, 1966; 28, 129–133.
  18. Matsuda, H., Li, Y., Murakami, T., Matsumura, N., Yamahara, J., & Yoshikawa, M. Antidiabetic principles of natural medicines III structure-related inhibitory activity and action model of oleanolic acid glycosides on hypoglycemic effect. Chemical and Pharmaceutical Bulletin, 1998; 46, 1399–1403.
  19. Khanna, P., Jain, S. C., Panagariya, A., & Dixit, V. P. Hypoglycemic activity of polypeptide-P from a plant source. Journal of Natural Products, 1981; 44(6), 648–655.
  20. Nag, B., Medicherla, S., & Sharma, S. D. Orally active fraction of Momordicacharantia, active peptides thereof, and their use in the treatment of diabetes. US Patent 2000; 6127338.
  21. Zhang, S. Y., Yao, W. Z., Xue, Q. F., Wang, G. Y., Han, J. H., Lei, Q. J., et al. Isolation, purification and characterization of peptides with hypoglycemic effect in MomordicaCharantia L. ActaBiochimica et BiophysicaSinica, 1980; 12(4), 391
  22. Sitasawad ,Sandhya L, YogitaShewade, Ramesh Bhonde . Role of bittergourd fruit juice in stzinduced diabetic state in vivo and in vitro Journal of Ethnopharmacology 2000; 73: 71–79
  23. Portha B, PICON L, ROSSELIN G: Chemical diabetes in the adult rats as the spontaneous evolution of neonatal diabetes. Diabetologia , 1979; 17: 371i377.
  24. Ahmed I, Cummings E, Adeghate E, Sharma AK, Singh J. Beneficial effects and mechanism of action of Momordicacharantia fruit juice in the treatment of streptozotocin-induced diabetes mellitus in rats. Mol Cell Biochem (2004) 26: 63–70
  25. Wolver TMS, Jenkins DJA. Effect of dietary fibre and foods on carbohydrate metabolism. In: Spiller GA (ed), CRC Handbook of Dietary Fibre in Human Nutrition. Florida: CRC Press, Inc., 1986; pp. 87– 119.
  26. Berggren AM, Bjorck IME, Nyman EMGL, Eggum BO. Short chain fatty acids content and pH in caecum of rats given various sources of carbohydrates. J Sci Food Agric, 1993;63: 397–404.
  27. Sarkar, S., Pranava, M., Manita, R. Demonstration of the hypoglycemic action of Momordicacharantia in a validated animal model of diabetes. Pharmacological Research 1996; 33, 1–4.
  28. Platel, K., Srinivasan, K. Effect of dietary intake of freeze dried bitter gourd (Momordicacharantia) in streptozotocin induced diabetic rats. Nahrung, 1995; 39, 262–268
  29. Karunanayake EH, Jeevathayaparan S, Tennekoon KH: Effect of Momordicacharantia fruit juice on streptozotocin-induced diabetes in rats. J Ethnopharmacol 1990;30: 199–204,
  30. Bailey CJ, Day C, Turner SL, Leatherdale BA: Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. 1985; 2: 81–84.
  31. J. Betteridge, Lipid disorders in diabetes mellitus, in: J.C. Pickup, G. Williams (Eds.), Text Book of Diabetes, second ed., Blackwell Science, London, 1997, pp. 55.1–55.31.
  32. Taskinen M. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41:12–17
  33. G.B. Brown, Z. Xue-Qiao, D.E. Sacco, J.J. Alberts, Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease, Circulation 87 (1993) 1781–1791.
  34. M. Laakso, Epidemiology of diabetic dyslipidemia, DiabeticRev. 3 (1995) 408–422.
  35. Kannel WB. Metabolic risk factors for coronary heart disease in women. Perspective from the Framingham study. Am Heart J 1987; 114:413–419
  36. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 1986; 287:413–41

Author Info

 

Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

iomcworld scan

Journal Highlights

Journal Flyer

Flyer